When a patient is referred to ACOC for chemotherapy, the first step is never a prescription — it is a conversation. Specifically, a tumor board conversation, where the patient's full clinical picture is reviewed by the complete multidisciplinary team before any treatment plan is agreed.
This approach is grounded in evidence. Multiple studies have shown that patients whose cases are reviewed by multidisciplinary teams receive more accurate staging, more appropriate treatment, and better outcomes than those managed by a single clinician.